{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:05:08Z","timestamp":1793397908753,"version":"4.5.0"},"reference-count":104,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T00:00:00Z","timestamp":1333497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The present paper considers naltrexone to treat opioid dependence during pregnancy. The public health problem of opioid dependence and its treatment during pregnancy is reviewed first. Next, the naltrexone and opioid dependence treatment literature is summarized, with overviews of the pre\u2010clinical and clinical research on prenatal naltrexone exposure. Finally, considerations and recommendations for future medication research for the treatment of opioid dependence in pregnant women are provided. The efficacy of long\u2010acting injectable naltrexone relative to placebo, its blockade of opioid agonist euphoric effects, its lack of abuse and tolerance development and its modest adverse effect profile make it a potential medication for opioid\u2010dependent pregnant women. However, it is not without seriously concerning potential drawbacks, including the difficulty surrounding medication induction that may lead to vulnerability with regard to relapse, physical dependence re\u2010establishment, increased risk behaviors, treatment dropout and resulting opioid overdose. Before embarking on future research with this medication, the benefits and risks for the mother\u2013embryo\/fetus\/child dyad should be weighed carefully. Should future research be conducted, a multi\u2010level commitment to proactive ethical research is needed to reach the ultimate goal of improving the lives of women and children affected by opioid dependence.<\/jats:p>","DOI":"10.1111\/j.1360-0443.2012.03811.x","type":"journal-article","created":{"date-parts":[[2012,4,4]],"date-time":"2012-04-04T07:33:58Z","timestamp":1333524838000},"page":"233-247","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Naltrexone in the treatment of opioid\u2010dependent pregnant women: the case for a considered and measured approach to research"],"prefix":"10.1111","volume":"108","author":[{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret S.","family":"Chisolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mishka","family":"Terplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,4,4]]},"reference":[{"key":"e_1_2_9_2_2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).EMCDDA. A gender perspective on drug use and responding to drug problems. Luxembourg:Office for the Official Publications of the European Communities;2006."},{"key":"e_1_2_9_3_2","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA).Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of National Findings. Rockville MD:SAMHSA;2010."},{"key":"e_1_2_9_4_2","first-page":"65","article-title":"Reproductive health needs: comparing women at high, drug\u2010related risk of HIV with a national sample","volume":"54","author":"Armstrong K. A.","year":"1999","journal-title":"J Am Med Womens Assoc"},{"key":"e_1_2_9_5_2","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA).Results from the 2008 National Survey on Drug Use and Health: National findings. Office of Applied Studies HHS Publication no. SMA 09\u20104434. Rockville MD:SAMHSA;2009."},{"key":"e_1_2_9_6_2","first-page":"410","article-title":"Combating abuse and diversion of prescription opiate medications","volume":"36","author":"Collins G.","year":"2006","journal-title":"Psychiatr Ann"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.75.2.269"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-1-5"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.63.1.81"},{"key":"e_1_2_9_10_2","first-page":"259","volume-title":"Perinatal Medicine: Management of the High Risk Fetus and Neonate","author":"Connaughton J. F.","year":"1977"},{"key":"e_1_2_9_11_2","first-page":"75","article-title":"Narcotic withdrawal in the newborn","volume":"6","author":"Glass L.","year":"1972","journal-title":"Am Fam Physician"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02877.x"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-3782(77)90017-2"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.113.6.1677"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(73)80550-5"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.101.6.1079"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01321293"},{"key":"e_1_2_9_18_2","unstructured":"Food and Drug Administration (FDA)\/New Drug Application (NDA) Guidance.State methadone maintenance treatment guidelines. Rockville MD:US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Treatment;1992."},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802266276"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.03.007"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(75)90492-5"},{"key":"e_1_2_9_22_2","first-page":"449","article-title":"Teratogenic activity of methadone hydrochloride in mouse and chick embryos","volume":"30","author":"Jurand A.","year":"1973","journal-title":"J Embryol Exp Morphol"},{"key":"e_1_2_9_23_2","first-page":"1367","volume-title":"Primary Pediatric Care","author":"Finnegan L. P.","year":"1992"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/0890334403261027"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.01.004"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2009.0079"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00056-5"},{"key":"e_1_2_9_28_2","unstructured":"REPROTOX.http:\/\/www.reprotox.org.2011. (accessed 4 March 2011). (Archived athttp:\/\/www.webcitation.org\/65kMVHwKyon 26 February 2012)."},{"key":"e_1_2_9_29_2","first-page":"509","article-title":"Toxicological studies of buprenorphine. II. Teratogenicity in rat","volume":"13","author":"Mori N.","year":"1982","journal-title":"Iyakuhin Kenkyu"},{"key":"e_1_2_9_30_2","first-page":"532","article-title":"Buprenorphine: toxicological studies of buprenorphine. III. Perinatal and postnatal study in rat","volume":"13","author":"Mori N.","year":"1982","journal-title":"Iyakuhin Kenkyu"},{"key":"e_1_2_9_31_2","unstructured":"KahilaH.Substance misuse problems during pregnancy with special emphasis on buprenorphine.http:\/\/urn.fi\/URN:ISBN:ISBN978-952-10-7204-8. (accessed 22 March 2012). (Archived athttp:\/\/www.webcitation.org\/66LckqSKton 22 March 2012)."},{"issue":"2","key":"e_1_2_9_32_2","article-title":"Maintenance agonist treatments for opiate dependent pregnant women","author":"Minozzi S.","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.10.001"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01321.x"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2008.01.025"},{"key":"e_1_2_9_37_2","unstructured":"CzerkesM. BlackstoneJ. PulvinoJ.Buprenorphine versus methadone treatment for opiate addiction in pregnancy: an evaluation of neonatal outcomes. San Francisco CA; American College of Obstetricians and Gynecologists;2010."},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"e_1_2_9_39_2","unstructured":"Food and Drug Administration. Letter to Akermes Inc.2010. Available at:http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2010\/021897s015ltr.pdf(accessed 4 March 2011). (Archived athttp:\/\/www.webcitation.org\/65kMsTxAfon 26 February 2012)."},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1973.01750360022003"},{"key":"e_1_2_9_41_2","first-page":"485","volume-title":"Goodman & Gilman's: The Pharmacological Basis of Therapeutics","author":"Jaffe J. H.","year":"1990"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(85)90136-2"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.16.8.1285"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198835030-00002"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2002.00217.x"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2003.tb00552.x"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.10.3.213"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.02.003"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2004.02.002"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001333.pub3"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00301-X"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2007.tb00840.x"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00654.x"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130100909"},{"key":"e_1_2_9_55_2","unstructured":"EverlyJ. J. UmbrichtA. FingerhoodM. BigelowG. SilvermanK.Employment\u2010based reinforcement of acceptance of depot naltrexone injections in opioid\u2010dependent adults. San Juan PR: Annual Meeting of the College on the Problems of Drug Dependence;2008."},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006140.pub2"},{"key":"e_1_2_9_57_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-010-0135-5"},{"key":"e_1_2_9_58_2","unstructured":"Food and Drug Administration.Vivitrol. Food and Drug Administration.2011(accessed 2 April 2011). (Archived athttp:\/\/www.webcitation.org\/65kNdiMdKon 26 February 2012)."},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.06.002"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2008.0036"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2007.06.013"},{"key":"e_1_2_9_62_2","unstructured":"Center for Substance Abuse Treatment.Pregnant substance\u2010using women: treatment improvement protocol #2. Rockville MD: Substance Abuse and Mental Health Services Administration;1993."},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9479612.x"},{"key":"e_1_2_9_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130051045"},{"key":"e_1_2_9_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/0753-3322(93)90080-5"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(87)90412-4"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7414330"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/0890334404266881"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00419-X"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(75)90277-X"},{"key":"e_1_2_9_71_2","first-page":"7","article-title":"Reproductive toxicity and teratology evaluations of naltrexone","volume":"45","author":"Christian M. S.","year":"1984","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_9_72_2","first-page":"197","volume-title":"Neurobehavioral Teratology","author":"Zagon I. S.","year":"1984"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0031-9384(97)00007-3"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.2174\/157015908784533842"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.3.2"},{"key":"e_1_2_9_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(97)00307-9"},{"key":"e_1_2_9_77_2","first-page":"1443","article-title":"Opioid growth factor (OGF) inhibits anchorage\u2010independent growth in human cancer cells","volume":"24","author":"Zagon I. S.","year":"2004","journal-title":"Int J Oncol"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-3057(01)00649-9"},{"key":"e_1_2_9_79_2","first-page":"295","article-title":"Effects of prenatal naloxone exposure on postnatal behavioral development of rats","volume":"3","author":"Vorhees C. V.","year":"1981","journal-title":"Neurobehav Toxicol Teratol"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90563-0"},{"key":"e_1_2_9_81_2","first-page":"427","article-title":"Opioid elements in development of the spontaneous motility of chick embryos","volume":"35","author":"Sedlacek J.","year":"1986","journal-title":"Physiol Bohemoslov"},{"key":"e_1_2_9_82_2","first-page":"19","article-title":"Behavioral effects of perinatal naltrexone exposure: a preliminary investigation","volume":"11","author":"Harry G. J.","year":"1979","journal-title":"Pharmacol Biochem Behav"},{"key":"e_1_2_9_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)02160-4"},{"key":"e_1_2_9_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(95)00168-V"},{"key":"e_1_2_9_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(80)90019-1"},{"key":"e_1_2_9_86_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2001.tb01322.x"},{"key":"e_1_2_9_87_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0004-8666.2002.548_14.x"},{"key":"e_1_2_9_88_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0004-8666.2003.00121.x"},{"key":"e_1_2_9_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0004-8666.2002.00104.x"},{"key":"e_1_2_9_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2003.10.001"},{"key":"e_1_2_9_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4530(80)90026-8"},{"key":"e_1_2_9_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-3057(86)90356-4"},{"key":"e_1_2_9_93_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-5-1000"},{"key":"e_1_2_9_94_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.050682"},{"key":"e_1_2_9_95_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1978.tb16769.x"},{"key":"e_1_2_9_96_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2008.tb01711.x"},{"key":"e_1_2_9_97_2","doi-asserted-by":"publisher","DOI":"10.1525\/jer.2010.5.1.93"},{"key":"e_1_2_9_98_2","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31818c2a27"},{"key":"e_1_2_9_99_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265160802331678"},{"key":"e_1_2_9_100_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.58.5.681"},{"key":"e_1_2_9_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(77)90652-4"},{"key":"e_1_2_9_102_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709183371212"},{"key":"e_1_2_9_103_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2011.532048"},{"key":"e_1_2_9_104_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550881003684871"},{"key":"e_1_2_9_105_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0954579410000623"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1360-0443.2012.03811.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1360-0443.2012.03811.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:19:37Z","timestamp":1698653977000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1360-0443.2012.03811.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,4]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/j.1360-0443.2012.03811.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1360-0443.2012.03811.x","archive":["Portico"],"relation":{},"ISSN":["0965-2140","1360-0443"],"issn-type":[{"value":"0965-2140","type":"print"},{"value":"1360-0443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,4]]},"assertion":[{"value":"2012-04-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}